- Filed
- Mar 18, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 17, 2025 | 19.09M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | $148.62M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $157.56M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $414.52M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $261.19M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 18.87M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $0 |
| Capex | FY 2024 · Dec 31, 2022 | $27.62M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $22.34M |
| Total Assets | FY 2024 · Dec 31, 2022 | $701.08M |
| Eps Diluted restated | FY 2024 · Dec 31, 2022 | $0.24 |
| Eps Basic restated | FY 2024 · Dec 31, 2022 | $0.24 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $7.08M |
| Net Income | FY 2024 · Dec 31, 2022 | $4.57M |
| Operating Income | FY 2024 · Dec 31, 2022 | $8M |
| Revenue | FY 2024 · Dec 31, 2022 | $37.48M |